Ascentage Pharma Group Stock Market Value

ASPHF Stock  USD 8.48  0.00  0.00%   
Ascentage Pharma's market value is the price at which a share of Ascentage Pharma trades on a public exchange. It measures the collective expectations of Ascentage Pharma Group investors about its performance. Ascentage Pharma is trading at 8.48 as of the 10th of February 2026. This is a No Change since the beginning of the trading day. The stock's lowest day price was 8.48.
With this module, you can estimate the performance of a buy and hold strategy of Ascentage Pharma Group and determine expected loss or profit from investing in Ascentage Pharma over a given investment horizon. Check out Ascentage Pharma Correlation, Ascentage Pharma Volatility and Ascentage Pharma Performance module to complement your research on Ascentage Pharma.
Symbol

Understanding that Ascentage Pharma's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Ascentage Pharma represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Ascentage Pharma's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Ascentage Pharma 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ascentage Pharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ascentage Pharma.
0.00
11/12/2025
No Change 0.00  0.0 
In 3 months and 1 day
02/10/2026
0.00
If you would invest  0.00  in Ascentage Pharma on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Ascentage Pharma Group or generate 0.0% return on investment in Ascentage Pharma over 90 days. Ascentage Pharma is related to or competes with Galenica, and Sugi Holdings. More

Ascentage Pharma Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ascentage Pharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ascentage Pharma Group upside and downside potential and time the market with a certain degree of confidence.

Ascentage Pharma Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Ascentage Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ascentage Pharma's standard deviation. In reality, there are many statistical measures that can use Ascentage Pharma historical prices to predict the future Ascentage Pharma's volatility.
Hype
Prediction
LowEstimatedHigh
5.998.4810.97
Details
Intrinsic
Valuation
LowRealHigh
5.427.9110.40
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Ascentage Pharma. Your research has to be compared to or analyzed against Ascentage Pharma's peers to derive any actionable benefits. When done correctly, Ascentage Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Ascentage Pharma.

Ascentage Pharma February 10, 2026 Technical Indicators

Ascentage Pharma Backtested Returns

Ascentage Pharma secures Sharpe Ratio (or Efficiency) of -0.0479, which signifies that the company had a -0.0479 % return per unit of standard deviation over the last 3 months. Ascentage Pharma Group exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Ascentage Pharma's mean deviation of 0.5103, and Risk Adjusted Performance of (0.03) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.0927, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Ascentage Pharma are expected to decrease at a much lower rate. During the bear market, Ascentage Pharma is likely to outperform the market. At this point, Ascentage Pharma has a negative expected return of -0.12%. Please make sure to confirm Ascentage Pharma's standard deviation, as well as the relationship between the maximum drawdown and day median price , to decide if Ascentage Pharma performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.00  

No correlation between past and present

Ascentage Pharma Group has no correlation between past and present. Overlapping area represents the amount of predictability between Ascentage Pharma time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ascentage Pharma price movement. The serial correlation of 0.0 indicates that just 0.0% of current Ascentage Pharma price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test-0.17
Residual Average0.0
Price Variance0.0

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in Ascentage Pink Sheet

When determining whether Ascentage Pharma is a strong investment it is important to analyze Ascentage Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ascentage Pharma's future performance. For an informed investment choice regarding Ascentage Pink Sheet, refer to the following important reports:
Check out Ascentage Pharma Correlation, Ascentage Pharma Volatility and Ascentage Pharma Performance module to complement your research on Ascentage Pharma.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Ascentage Pharma technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Ascentage Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Ascentage Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...